Introduction

The recent IPO that brought the consumer health business of Johnson & Johnson under a new umbrella called Kenview. How good of a move was this by J&J? David Shoe is a management professor here at the Wharton School. He says it follows companies like GSK, who together with Novartis and Pfizer spun off a company called Halion.